Gulf War Drug Experiment

Some of the 250,000 U.S. troop members who were vaccinated against chemical weapons during the Gulf War received an experimental drug without their consent, news sources report.

The Pentagon made a "conscious decision" not to tell the troops for fear of alerting Iraq to U.S. defenses against chemical attacks, spokesman Navy Capt. Michael Doubleday told reporters Thursday. He advised veterans "not to jump to any conclusions" about the potential effects of the drug and nerve gas exposure.

The drug, pyridostigmine bromide, or PB, is not a Food and Drug Administration-approved pre-treatment against nerve gas, but the FDA agreed to allow the administration of the drug to soldiers because results from Army animal studies showed it provided protection against certain types of gas.

The Defense Department did not get consent from the soldiers vaccinated with the drug because of a wartime waiver granted by the FDA. But Pentagon officials said in the briefing yesterday they should have been more open with the troops.

Stay up-to-date with federal news alerts and analysis — Sign up for GovExec's email newsletters.
Close [ x ] More from GovExec

Thank you for subscribing to newsletters from
We think these reports might interest you:

  • Sponsored by eSignLive by VASCO

    Mobile E-Signatures for Government

    Learn 5 key trends that accelerate government demand for mobile signing.

  • Sponsored by Management Concepts

    SPONSORED: Successful Change Management Practices in the Public Sector

    How governmental agencies implement organizational change management.

  • Sponsored by Kronos

    Solving the Workforce Compliance Challenge

    Download this eBook to learn how data and automation can help state and local agencies.


When you download a report, your information may be shared with the underwriters of that document.